{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T05:23:17Z","timestamp":1792041797514,"version":"4.4.0"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2019,4,2]],"date-time":"2019-04-02T00:00:00Z","timestamp":1554163200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100009592","name":"Beijing Municipal Science & Technology Commission","doi-asserted-by":"crossref","award":["Z171100001017136"],"award-info":[{"award-number":["Z171100001017136"]}],"id":[{"id":"10.13039\/501100009592","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"publisher","award":["7171001"],"award-info":[{"award-number":["7171001"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Open Project funded by Key laboratory of Carcinogenesis and Translational Research, Ministry of Education","award":["2017 Open Project-3"],"award-info":[{"award-number":["2017 Open Project-3"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Extranodal natural killer (NK) cell\/T-cell lymphoma (NKTCL), a rare type of non-Hodgkin's lymphoma, has strongly been associated with Epstein-Barr virus (EBV) infection. However, there are no EBV genomes isolated from NKTCL, and the roles the variations of EBV strains play in the pathogenesis of NKTCL are still unclear.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Materials and Methods<\/jats:title>\n                  <jats:p>In this study, whole EBV genomes from eight primary NKTCL biopsy specimens were obtained using next-generation sequencing, designated NKTCL-EBV1 to NKTCL-EBV8.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Compared with the six mostly referenced EBV strains, NKTCL-EBVs closely resemble the GD1 strain but still harbor 2,072 variations, including 1,938 substitutions, 58 insertions, and 76 deletions. The majority of nonsynonymous mutations were located in latent and tegument genes. Moreover, the results from phylogenetic analysis of whole NKTCL genomes and specific genes demonstrated that all the NKTCL-EBVs were related to Asian EBV strains. Based on the amino acid changes in certain residues of latent membrane protein 1 (LMP1) and EBV-determined nuclear antigen 1 (EBNA1), all the NKTCL-EBVs were sorted to China 1 and V-val subtype, respectively. Furthermore, changes in CD4+ and CD8+ T-cell epitopes of EBNA1 and LMP1 may affect the efficacy for a cytotoxic T lymphocyte (CTL)-based therapy.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>This is the first large study to our knowledge to obtain EBV genomes isolated from NKTCL and show the diversity of EBV genomes in a whole genome level by phylogenetic analysis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Implications for Practice<\/jats:title>\n                  <jats:p>In this study, the full-length sequence of Epstein-Barr virus (EBV) isolated from eight patients with nasal natural killer\/T-cell lymphoma (NKTCL) was determined and further compared with the sequences previously reported isolated from other malignancies. Phylogenetic analysis showed that NKTCL-EBV strains are close to other Asian subtypes instead of non-Asian ones, leading to the conclusion that EBV infections are more likely affected by different geographic regions rather than particular EBV-associated malignancies. Therefore, these data have implications for the development of effective prophylactic and therapeutic vaccine approaches targeting the personalized or geographic-specific EBV antigens in these aggressive diseases.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1634\/theoncologist.2017-0588","type":"journal-article","created":{"date-parts":[[2019,4,2]],"date-time":"2019-04-02T18:05:11Z","timestamp":1554228311000},"page":"e905-e913","source":"Crossref","is-referenced-by-count":9,"title":["Genome-Wide Analysis of Epstein-Barr Virus Isolated from Extranodal NK\/T-Cell Lymphoma, Nasal Type"],"prefix":"10.1093","volume":"24","author":[{"given":"Ningjing","family":"Lin","sequence":"first","affiliation":[{"name":"Department of Lymphoma, Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Ku","sequence":"additional","affiliation":[{"name":"Laboratory of Biochemistry and Molecular Biology, Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqin","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Lymphoma, Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Lymphoma, Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheming","family":"Lu","sequence":"additional","affiliation":[{"name":"Laboratory of Biochemistry and Molecular Biology, Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,4,2]]},"reference":[{"key":"2021122507540419700_onco12925-bib-0001","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2174\/1871526516666160407113536","article-title":"EBV-related malignancies, outcomes and novel prevention strategies","volume":"16","author":"Ozoya","year":"2016","journal-title":"Infect Disord Drug Targets"},{"key":"2021122507540419700_onco12925-bib-0002","first-page":"12","article-title":"Extranodal natural killer\/T cell lymphoma: We should and we can do more","volume":"4","author":"Ying","year":"2015","journal-title":"Chin Clin Oncol"},{"key":"2021122507540419700_onco12925-bib-0003","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/ijc.2910440112","article-title":"Nation-wide study of lethal mid-line granuloma in Japan: Frequencies of wegener's granulomatosis, polymorphic reticulosis, malignant lymphoma and other related conditions","volume":"44","author":"Aozasa","year":"1989","journal-title":"Int J Cancer"},{"key":"2021122507540419700_onco12925-bib-0004","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3324\/haematol.2017.180430","article-title":"Epstein-Barr virus-associated primary nodal T\/NK-cell lymphoma shows a distinct molecular signature and copy number changes","volume":"103","author":"Ng","year":"2018","journal-title":"Haematologica"},{"key":"2021122507540419700_onco12925-bib-0005","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1002\/(SICI)1097-0142(19960515)77:10<2137::AID-CNCR27>3.0.CO;2-V","article-title":"Nasal T-cell lymphoma causally associated with Epstein-Barr virus: Clinicopathologic, phenotypic, and genotypic studies","volume":"77","author":"Harabuchi","year":"1996","journal-title":"Cancer"},{"key":"2021122507540419700_onco12925-bib-0006","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1756-8722-6-44","article-title":"A prospective phase II study of L-asparaginase- CHOP plus radiation in newly diagnosed extranodal NK\/T-cell lymphoma, nasal type","volume":"6","author":"Lin","year":"2013","journal-title":"J Hematol Oncol"},{"key":"2021122507540419700_onco12925-bib-0007","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1200\/JCO.2005.04.1384","article-title":"Extranodal natural killer T-cell lymphoma, nasal-type: A prognostic model from a retrospective multicenter study","volume":"24","author":"Lee","year":"2006","journal-title":"J Clin Oncol"},{"key":"2021122507540419700_onco12925-bib-0008","first-page":"55","article-title":"Characteristics of nasal T\/NK-cell lymphoma among Brazilians","volume":"49","author":"Altemani","year":"2002","journal-title":"Neoplasma"},{"key":"2021122507540419700_onco12925-bib-0009","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1182\/blood-2012-06-435024","article-title":"Clinical implications of plasma Epstein-Barr virus DNA in early-stage extranodal nasal-type NK\/T-cell lymphoma patients receiving primary radiotherapy","volume":"120","author":"Wang","year":"2012","journal-title":"Blood"},{"key":"2021122507540419700_onco12925-bib-0010","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/310207a0","article-title":"DNA sequence and expression of the B95-8 epstein-barr virus genome","volume":"310","author":"Baer","year":"1984","journal-title":"Nature"},{"key":"2021122507540419700_onco12925-bib-0011","doi-asserted-by":"crossref","first-page":"4903","DOI":"10.18632\/oncotarget.6751","article-title":"Genome-wide analysis of Epstein-Barr virus (EBV) isolated from EBV-associated gastric carcinoma (EBVaGC)","volume":"7","author":"Liu","year":"2016","journal-title":"Oncotarget"},{"key":"2021122507540419700_onco12925-bib-0012","doi-asserted-by":"crossref","first-page":"26156","DOI":"10.1038\/srep26156","article-title":"Identification and characterization of Epstein-Barr virus genomes in lung carcinoma biopsy samples by next-generation sequencing technology","volume":"6","author":"Wang","year":"2016","journal-title":"Sci Rep"},{"key":"2021122507540419700_onco12925-bib-0013","doi-asserted-by":"crossref","first-page":"10662","DOI":"10.1128\/JVI.01665-14","article-title":"Genomic diversity of Epstein-Barr virus genomes isolated from primary nasopharyngeal carcinoma biopsy samples","volume":"88","author":"Kwok","year":"2014","journal-title":"J Virol"},{"key":"2021122507540419700_onco12925-bib-0014","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s10147-009-0882-7","article-title":"Nasal natural killer (NK)\/T-cell lymphoma: Clinical, histological, virological, and genetic features","volume":"14","author":"Harabuchi","year":"2009","journal-title":"Int J Clin Oncol"},{"key":"2021122507540419700_onco12925-bib-0015","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.virol.2006.01.015","article-title":"The genome of Epstein-Barr virus type 2 strain AG876","volume":"350","author":"Dolan","year":"2006","journal-title":"Virology"},{"key":"2021122507540419700_onco12925-bib-0016","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0036939","article-title":"Genomic sequencing and comparative analysis of Epstein-Barr virus genome isolated from primary nasopharyngeal carcinoma biopsy","volume":"7","author":"Kwok","year":"2012","journal-title":"PLoS One"},{"key":"2021122507540419700_onco12925-bib-0017","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1186\/1471-2164-14-804","article-title":"Identification and characterization of EBV genomes in spontaneously immortalized human peripheral blood B lymphocytes by NGS technology","volume":"14","author":"Lei","year":"2013","journal-title":"BMC Genomics"},{"key":"2021122507540419700_onco12925-bib-0018","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1128\/JVI.02517-12","article-title":"Whole-genome sequencing of the Akata and Mutu Epstein-Barr virus strains","volume":"87","author":"Lin","year":"2013","journal-title":"J Virol"},{"key":"2021122507540419700_onco12925-bib-0019","doi-asserted-by":"crossref","first-page":"11291","DOI":"10.1128\/JVI.00823-11","article-title":"Direct sequencing and characterization of a clinical isolate of Epstein-Barr virus from nasopharyngeal carcinoma tissue by using next-generation sequencing technology","volume":"85","author":"Liu","year":"2011","journal-title":"J Virol"},{"key":"2021122507540419700_onco12925-bib-0020","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0042-6822(90)90302-8","article-title":"Sequence and transcription of Raji Epstein-Barr virus DNA spanning the B95-8 deletion region","volume":"179","author":"Parker","year":"1990","journal-title":"Virology"},{"key":"2021122507540419700_onco12925-bib-0021","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/272629a0","article-title":"A new tumour-derived transforming strain of Epstein-Barr virus","volume":"272","author":"Pizzo","year":"1978","journal-title":"Nature"},{"key":"2021122507540419700_onco12925-bib-0022","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1750-9378-8-29","article-title":"Complete genomic sequence of Epstein-Barr virus in nasopharyngeal carcinoma cell line C666-1","volume":"8","author":"Tso","year":"2013","journal-title":"Infect Agent Cancer"},{"key":"2021122507540419700_onco12925-bib-0023","doi-asserted-by":"crossref","first-page":"15323","DOI":"10.1128\/JVI.79.24.15323-15330.2005","article-title":"Genomic sequence analysis of Epstein-Barr virus strain GD1 from a nasopharyngeal carcinoma patient","volume":"79","author":"Zeng","year":"2005","journal-title":"J Virol"},{"key":"2021122507540419700_onco12925-bib-0024","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1107\/S0907444906030034","article-title":"Structural genomics of the Epstein-Barr virus","volume":"62","author":"Tarbouriech","year":"2006","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"2021122507540419700_onco12925-bib-0025","first-page":"177","article-title":"Variation in the sequence of Epstein-Barr virus nuclear antigen 1 in normal peripheral blood lymphocytes and in Burkitt's lymphomas","volume":"13","author":"Bhatia","year":"1996","journal-title":"Oncogene"},{"key":"2021122507540419700_onco12925-bib-0026","first-page":"1545","article-title":"Alterations in the structure of the EBV nuclear antigen, EBNA1, in epithelial cell tumours","volume":"10","author":"Snudden","year":"1995","journal-title":"Oncogene"},{"key":"2021122507540419700_onco12925-bib-0027","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/jmv.10305","article-title":"EBNA-1 sequence variations reflect active EBV replication and disease status or quiescent latency in lymphocytes","volume":"69","author":"Wang","year":"2003","journal-title":"J Med Virol"},{"key":"2021122507540419700_onco12925-bib-0028","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.virusres.2007.10.020","article-title":"A major EBNA1 variant from Asian EBV isolates shows enhanced transcriptional activity compared to prototype B95.8","volume":"132","author":"Do","year":"2008","journal-title":"Virus Res"},{"key":"2021122507540419700_onco12925-bib-0029","doi-asserted-by":"crossref","first-page":"5222","DOI":"10.1128\/JVI.03614-14","article-title":"Genome diversity of Epstein-Barr virus from multiple tumor types and normal infection","volume":"89","author":"Palser","year":"2015","journal-title":"J Virol"},{"key":"2021122507540419700_onco12925-bib-0030","doi-asserted-by":"crossref","first-page":"6458","DOI":"10.1128\/JVI.00135-06","article-title":"LMP1 strain variants: Biological and molecular properties","volume":"80","author":"Mainou","year":"2006","journal-title":"J Virol"},{"key":"2021122507540419700_onco12925-bib-0031","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1006\/viro.1999.9855","article-title":"Signature amino acid changes in latent membrane protein 1 distinguish Epstein-Barr virus strains","volume":"261","author":"Edwards","year":"1999","journal-title":"Virology"},{"key":"2021122507540419700_onco12925-bib-0032","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.virusres.2009.07.005","article-title":"The extent of genetic diversity of Epstein-Barr virus and its geographic and disease patterns: A need for reappraisal","volume":"143","author":"Chang","year":"2009","journal-title":"Virus Res"},{"key":"2021122507540419700_onco12925-bib-0033","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11262-006-0008-5","article-title":"Sequence variations of Epstein-Barr virus LMP1 gene in nasal NK\/T-cell lymphoma","volume":"34","author":"Nagamine","year":"2007","journal-title":"Virus Genes"},{"key":"2021122507540419700_onco12925-bib-0034","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1136\/jcp.2005.034199","article-title":"Nasal natural killer\/T-cell lymphoma and its association with type \u201ci\u201d\/xho I loss strain epstein-barr virus in chile","volume":"60","author":"Cabrera","year":"2007","journal-title":"J Clin Pathol"},{"key":"2021122507540419700_onco12925-bib-0035","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1038\/sj.onc.1210240","article-title":"Epstein-Barr virus infection in humans: From harmless to life endangering virus-lymphocyte interactions","volume":"26","author":"Klein","year":"2007","journal-title":"Oncogene"},{"key":"2021122507540419700_onco12925-bib-0036","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.1182\/blood-2010-06-292268","article-title":"A novel latent membrane 2 transcript expressed in Epstein-Barr virus-positive NK- and T-cell lymphoproliferative disease encodes a target for cellular immunotherapy","volume":"116","author":"Fox","year":"2010","journal-title":"Blood"},{"key":"2021122507540419700_onco12925-bib-0037","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1200\/JCO.2013.51.5304","article-title":"Sustained complete responses in patients with lymphoma receiving autologous cytotoxic T lymphocytes targeting Epstein-Barr virus latent membrane proteins","volume":"32","author":"Bollard","year":"2014","journal-title":"J Clin Oncol"},{"key":"2021122507540419700_onco12925-bib-0038","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1038\/mt.2015.91","article-title":"Long-term outcome of extranodal NK\/T cell lymphoma patients treated with postremission therapy using EBV LMP1 and LMP2a-specific CTLs","volume":"23","author":"Cho","year":"2015","journal-title":"Mol Ther"},{"key":"2021122507540419700_onco12925-bib-0039","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s11373-005-9017-y","article-title":"Functional assays of HLA A2-restricted epitope variant of latent membrane protein 1 (LMP-1) of Epstein-Barr virus in nasopharyngeal carcinoma of Southern China and Taiwan","volume":"12","author":"Lin","year":"2005","journal-title":"J Biomed Sci"}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1634\/theoncologist.2017-0588","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1634\/theoncologist.2017-0588","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/24\/9\/e905\/41917856\/oncolo_24_9_e905.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/24\/9\/e905\/41917856\/oncolo_24_9_e905.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,25]],"date-time":"2021-12-25T07:55:43Z","timestamp":1640418943000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/24\/9\/e905\/6439473"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,2]]},"references-count":39,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2019,4,2]]},"published-print":{"date-parts":[[2019,9,1]]}},"URL":"https:\/\/doi.org\/10.1634\/theoncologist.2017-0588","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"value":"1083-7159","type":"print"},{"value":"1549-490X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,9,1]]},"published":{"date-parts":[[2019,4,2]]}}}